Abstract 22: Late Functional Improvement in Acute Ischemic Stroke Patients

    loading  Checking for direct PDF access through Ovid

Abstract

Background: Most studies recruiting patients with acute ischemic stroke ascertain the final functional status at 3 months post symptom onset. The rates and predictors of late functional improvement (>3 months) in acute ischemic stroke patients has not been systemically studied.

Methods: We analyzed data from three phase-III randomized multicenter clinical trials that recruited acute ischemic stroke patients within 3 or within 5 hours of symptoms onset. Late improvement was defined by an improvement of 1 or more grade in modified Rankin scale between ascertainments performed at 3 and 12 months post randomization. We analyzed the rates of late improvement in three groups of patients; patients treated with IV (recombinant tissue plasminogen activator [rt-PA], those treated with endovascular treatment, and those not treated with any acute reperfusion treatment. Multivariate analysis was performed to identify predictors’ of late functional improvement.

Results: A total of 2555 patients (mean age ± SD; 66.4 ± 12.9 years) with acute ischemic stroke were analyzed.Late functional improvement was observed in 447 (17.5%, 95% confidence interval [CI] 15.9 to 19.2]) of 2555 patients analyzed. The rates of late functional improvement according to acute reperfusion treatment were as follows: 248 (22.4%) of 1106 in IV rt-PA treated; 108 (23.9%) of 452 in endovascular treated; and 91 (19.1%) of 477 in patients without any treatment (p= 0.179). In multivariate analysis, patients with age ≥65 years (odds ratio [OR], 0.53; 95 % CI 0.35 to 0.80; P = 0.002), and severity of baseline neurological deficits with National Institutes of Health Stroke Scale [NIHSS] score at 24 hours ≥ 20 (OR, 0.40; 95 % CI, 0.28 to 0.58; P = <0.001), were inversely associated with late improvement.

Conclusions: Late functional improvement occurs in one fourth of acute ischemic stroke patients and should be considered in estimation of functional recovery in future clinical studies.

Related Topics

    loading  Loading Related Articles